Sleep deprivation and arrhythmias: Why late nights put young hearts at risk

Long-term sleep deprivation significantly impacts the body, disrupting essential restorative functions and leading to health ...

AI model helps diagnose often undetected heart disease from simple EKG

Doctors may soon be able to diagnose an elusive form of heart disease within seconds by using an AI model developed at ...
Medical Device Network on MSN

FDA clears HeartBeam’s at-home arrhythmia assessment tool

HeartBeam has secured US Food and Drug Administration (FDA) clearance for its 12-lead electrocardiogram (ECG) synthesis ...
Fierce Pharma

Milestone wins 1st-ever FDA approval with green light for heart arrhythmia nasal spray

Clearing clinical and regulatory hurdles in the development of a fast-acting nasal spray for a heart condition has given ...

Milestone Pharmaceuticals Shares Gain After Arrhythmia Treatment Receives FDA Approval

Shares of Milestone Pharmaceuticals climbed after the company said its first commercial product, Cardamyst nasal spray, was approved by the Food and Drug Administration to treat paroxysmal ...

HeartBeam Receives FDA Clearance for First-Ever, Cable-Free Synthesized 12-Lead ECG for At-Home Arrhythmia Assessment

HeartBeam Receives FDA Clearance for First-Ever, Cable-Free Synthesized 12-Lead ECG for At-Home Arrhythmia Assessment ...

Huxley Medical's SANSA Receives Diagnostic ECG Clearance from FDA, Paving Way for First Solution to Systematically Detect Arrhythmias During Home Sleep Testing

Huxley Medical, Inc. announced the SANSA(R) home sleep apnea test has received regulatory clearance from the United States Food and Drug Administration (FDA) to be used as a diagnostic ECG monitor, ...
Medscape

ECG Challenge: Heart Rhythms After Angioplasty and Stenting

A 65-year-old man receives a right coronary artery stent after a NSTEMI. What does his postsurgery ECG look like?

Telomir Pharmaceuticals Reports Favorable IND-Enabling GLP Safety Results for Telomir-1 Supporting First-in-Human Clinical Development

No treatment-related adverse toxicity was observed across completed GLP studies, with consistent systemic exposure following oral administration. MIAMI, FL / ACCESS Newswire / December 18, 2025 / ...
MedPage Today on MSN

Etripamil Gets FDA Approval for At-Home Tachycardia Conversion

The FDA approved etripamil (Cardamyst) nasal spray for at-home treatment of paroxysmal supraventricular tachycardia (PSVT), ...
MassDevice

HeartBeam earns FDA clearance for first-ever cable-free 12-lead ECG for at-home arrhythmia assessment

HeartBeam (Nasdaq:BEAT) announced today that it received FDA 510(k) clearance for its 12-lead electrocardiogram (ECG) ...
The American Journal of Managed Care

FDA Approves Intranasal Etripamil for Type of Arrhythmia

The FDA has approved intranasal etripamil (Cardamyst; Milestone Pharmaceuticals) for the acute treatment of paroxysmal supraventricular tachycardia (PSVT), making it the first self-administered, ...